Log In
BCIQ
Print this Print this
 

P2745

  Manage Alerts
Collapse Summary General Information
Company Piramal Enterprises Ltd.
DescriptionOral inhibitor of transforming growth factor beta (TGFbeta) pathway
Molecular Target Transforming growth factor (TGF) beta 1 (TGFB1)
Mechanism of ActionTransforming growth factor (TGF) beta 1 inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationChronic myelogenous leukemia (CML)
Indication DetailsTreat chronic myelogenous leukemia (CML)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today